praxis-text-mobile

News

The Perils of Impatience and the Risk of Rapid Research

Share This Post

You may be aware of the much discussed retraction last week of the #Lancet article which claimed that hydroxychloroquine was associated with increased in-hospital mortality and ventricular arrhythmia when used to treat #Covid19.

The harms caused by this publication are many. Importantly, it causes the public to question their faith in #medicine, #research and #clinicaltrials and damages the case for the use of #AI and #RWD in #clinicaltrials. Critical right now, as we turn to research to answer the questions about tackling this pandemic.

The failures are at many levels, including the #peerreview process. In this #Nature briefing, our PRAXIS Australia Ltd Director, Ian Kerridge, and Macquarie Uni Bioethicist, Wendy Rogers, discuss some of the critical and ongoing impacts of this paper.

#researchfraud #integrity #clinicaltrials #realworlddata #peerreview#hydroxychloroquine #lancetgate

Link to full article: https://idp.nature.com/authorize?response_type=cookie&client_id=grover&redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-020-01695-w

Sign up to our mailing list to receive exclusive offers